Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,907 | 948 | 98.2% |
| Education | $247.95 | 6 | 1.8% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,130 | 278 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,694 | 140 | $0 (2024) |
| Janssen Biotech, Inc. | $1,042 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,011 | 84 | $0 (2024) |
| Gilead Sciences, Inc. | $841.91 | 41 | $0 (2024) |
| PFIZER INC. | $616.31 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $433.44 | 28 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $402.36 | 22 | $0 (2024) |
| Celgene Corporation | $391.05 | 31 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $321.80 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,054 | 57 | ABBVIE INC. ($347.90) |
| 2023 | $2,292 | 155 | AbbVie Inc. ($987.36) |
| 2022 | $2,089 | 145 | ABBVIE INC. ($576.99) |
| 2021 | $2,122 | 131 | AbbVie Inc. ($618.45) |
| 2020 | $1,676 | 117 | AbbVie Inc. ($468.01) |
| 2019 | $1,544 | 105 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($386.36) |
| 2018 | $1,658 | 121 | Gilead Sciences, Inc. ($261.16) |
| 2017 | $1,721 | 127 | AbbVie, Inc. ($514.48) |
All Payment Transactions
958 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $19.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Immunology | ||||||
| 05/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: GI | ||||||
| 05/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.26 | General |
| 05/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/06/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $89.00 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Immunology | ||||||
| 04/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 03/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 724 | 1,070 | $367,672 | $84,884 |
| 2022 | 15 | 839 | 929 | $388,300 | $90,215 |
| 2021 | 16 | 1,230 | 1,429 | $355,106 | $105,511 |
| 2020 | 15 | 1,160 | 1,364 | $326,660 | $92,825 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 84 | 84 | $89,628 | $16,825 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 172 | 215 | $31,820 | $12,930 | 40.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 69 | 69 | $53,682 | $12,294 | 22.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 104 | 111 | $68,524 | $11,353 | 16.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 207 | $31,464 | $7,420 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $16,863 | $5,602 | 33.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 116 | $11,600 | $5,539 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 51 | $11,067 | $4,410 | 39.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 74 | 83 | $27,722 | $2,536 | 9.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $9,372 | $2,054 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,312 | $1,695 | 31.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 17 | $8,806 | $1,603 | 18.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,812 | $622.43 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 191 | $40,688 | $17,549 | 43.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 82 | 82 | $82,524 | $15,356 | 18.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 105 | 111 | $62,470 | $11,712 | 18.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 52 | 52 | $39,321 | $9,442 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 132 | $17,236 | $7,053 | 40.9% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 38 | 38 | $32,318 | $5,972 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $12,765 | $4,817 | 37.7% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $20,270 | $4,155 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $9,357 | $3,102 | 33.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 32 | $16,114 | $3,016 | 18.7% |
| 43450 | Dilation of esophagus | Facility | 2022 | 70 | 87 | $27,617 | $2,748 | 9.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $8,410 | $2,032 | 24.2% |
About Dr. Timothy Trainor, M.D
Dr. Timothy Trainor, M.D is a Gastroenterology healthcare provider based in Slidell, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871555136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Trainor, M.D has received a total of $14,155 in payments from pharmaceutical and medical device companies, with $1,054 received in 2024. These payments were reported across 958 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($13,907).
As a Medicare-enrolled provider, Trainor has provided services to 3,953 Medicare beneficiaries, totaling 4,792 services with total Medicare billing of $373,434. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Slidell, LA
- Active Since 04/03/2006
- Last Updated 02/29/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1871555136
Products in Payments
- XIFAXAN (Drug) $889.30
- RINVOQ (Biological) $848.18
- HUMIRA (Biological) $839.75
- STELARA (Biological) $763.45
- XELJANZ (Drug) $588.84
- TRULANCE (Drug) $586.61
- ENTYVIO (Biological) $578.83
- SKYRIZI (Biological) $568.73
- Humira (Biological) $554.54
- LINZESS (Drug) $463.60
- ZEPOSIA (Drug) $376.62
- DIFICID (Drug) $365.80
- OCALIVA (Drug) $326.09
- VIBERZI (Drug) $309.01
- Linzess (Drug) $299.43
- Trulance (Drug) $270.11
- REMICADE (Biological) $253.63
- Creon (Drug) $233.91
- DUPIXENT (Biological) $212.79
- MOTEGRITY (Drug) $185.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Slidell
Edward Dauterive, M.d, M.D
Gastroenterology — Payments: $63,459
Anthony Albright, M.d, M.D
Gastroenterology — Payments: $22,879
Veronica Dugan, M.d, M.D
Gastroenterology — Payments: $18,530
Kimberly Dalmau, M.d, M.D
Gastroenterology — Payments: $2,310
Dasarathy Srinivas, M.d, M.D
Gastroenterology — Payments: $1,456
Malcolm Andry, M.d, M.D
Gastroenterology — Payments: $205.02